Dr. Sheldon Lidofsky, MD
Gastroenterology (Gastroenterology Physician)
33 Staniford St
Providence, RI 02905
Who else practices at this address →
Providence County includes mental health (6% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- State University of New York Downstate Medical Center (1975)
- Years since graduation
- 51
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 302
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1975Medical school: State University of New York Downstate Medical Center
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
RI license 5933
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Miriam Hospital Providence, RI
- Rhode Island Hospital Providence, RI
- Kent County Memorial Hospital Warwick, RI
- Women & Infants Hospital of Rhode Island Providence, RI
Medical groups
- University Gastroenterology, LLC (102 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 302
- Services billed
- 644
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 154 | 145 |
| Established patient office or other outpatient visit, 30-39 minutes | 117 | 78 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 88 | 81 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 80 | 80 |
| Imaging of digestive tract done from the inside of the digestive tract | 51 | 49 |
| Biopsy of large bowel using a flexible endoscope | 33 | 33 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | 26 |
| Established patient office or other outpatient visit, 40-54 minutes | 15 | 13 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Omeprazole Other prescribers in Providence, RI | 341 |
| Pantoprazole Sodium Other prescribers in Providence, RI | 214 |
| Famotidine Other prescribers in Providence, RI | 202 |
| Mesalamine Other prescribers in Providence, RI | 45 |
| Stelara (ustekinumab) | 32 |
| Dexlansoprazole Dr (dexlansoprazole) Other prescribers in Providence, RI | 26 |
| Esomeprazole Magnesium Other prescribers in Providence, RI | 24 |
| Sulfasalazine Other prescribers in Providence, RI | 21 |
| Balsalazide Disodium | 18 |
| Mesalamine Er (mesalamine) Other prescribers in Providence, RI | 16 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 99 payments worth $1,711 in total to this clinician.
| AbbVie Inc. | $787 |
|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $211 |
| Gilead Sciences, Inc. | $184 |
| Janssen Biotech, Inc. | $183 |
| Pfizer Inc. | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | $75.28 |
| Intercept Pharmaceuticals, Inc. | $29.74 |
| Fresenius Kabi USA, LLC | $26.42 |
| Food and Beverage | $1,590 |
|---|---|
| Education | $121 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Jun 23, 2025 | Education TREMFYA · Immunology · in-kind | $84.99 |
| Merck Sharp & Dohme LLC Jul 8, 2025 | Education IMMUNOLOGY · in-kind | $25.70 |
| Janssen Pharmaceuticals, Inc Apr 10, 2025 | Education in-kind | $10.48 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $33,875 in research payments for these studies, mostly to the institutions running them.
- An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice
E.r. Squibb & Sons, L.l.c. · Terminated · NCT05369832 - A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Eli Lilly and Company · Active, not recruiting · NCT04232553
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.